These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 37695590)

  • 1. Engineered Exosomes as Theranostic Platforms for Cancer Treatment.
    Yang X; Xie X; Liu S; Ma W; Zheng Z; Wei H; Yu CY
    ACS Biomater Sci Eng; 2023 Oct; 9(10):5479-5503. PubMed ID: 37695590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome Biochemistry and Advanced Nanotechnology for Next-Generation Theranostic Platforms.
    Yang B; Chen Y; Shi J
    Adv Mater; 2019 Jan; 31(2):e1802896. PubMed ID: 30126052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome-based delivery nanoplatforms: next-generation theranostic platforms for breast cancer.
    Zheng Y; Li M; Weng B; Mao H; Zhao J
    Biomater Sci; 2022 Mar; 10(7):1607-1625. PubMed ID: 35188522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.
    Tian J; Han Z; Song D; Peng Y; Xiong M; Chen Z; Duan S; Zhang L
    Int J Nanomedicine; 2023; 18():7923-7940. PubMed ID: 38152837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease.
    Li DF; Yang MF; Xu J; Xu HM; Zhu MZ; Liang YJ; Zhang Y; Tian CM; Nie YQ; Shi RY; Wang LS; Yao J
    Int J Nanomedicine; 2022; 17():3893-3911. PubMed ID: 36092245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome: From biology to drug delivery.
    Baruah H; Sarma A; Basak D; Das M
    Drug Deliv Transl Res; 2024 Jun; 14(6):1480-1516. PubMed ID: 38252268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can nanotechnology help membrane vesicle-based cancer immunotherapy development?
    Tian X; Zhu M; Nie G
    Hum Vaccin Immunother; 2013 Jan; 9(1):222-5. PubMed ID: 23108359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome-like Nanovectors for Drug Delivery in Cancer.
    Arrighetti N; Corbo C; Evangelopoulos M; Pastò A; Zuco V; Tasciotti E
    Curr Med Chem; 2019; 26(33):6132-6148. PubMed ID: 30182846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.
    Chen Z; Krishnamachary B; Pachecho-Torres J; Penet MF; Bhujwalla ZM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1595. PubMed ID: 31642207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and regulation of exosome-based therapy products.
    Batrakova EV; Kim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post isolation modification of exosomes for nanomedicine applications.
    Hood JL
    Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
    Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
    Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-like systems: Nanotechnology to overcome challenges for targeted cancer therapies.
    García-Fernández J; Fuente Freire M
    Cancer Lett; 2023 May; 561():216151. PubMed ID: 37001751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review.
    Donoso-Quezada J; Ayala-Mar S; González-Valdez J
    Crit Rev Biotechnol; 2020 Sep; 40(6):804-820. PubMed ID: 32605394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes: Multiple-targeted multifunctional biological nanoparticles in the diagnosis, drug delivery, and imaging of cancer cells.
    Zheng Y; Hasan A; Nejadi Babadaei MM; Behzadi E; Nouri M; Sharifi M; Falahati M
    Biomed Pharmacother; 2020 Sep; 129():110442. PubMed ID: 32593129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2D Nanomaterials for Cancer Theranostic Applications.
    Cheng L; Wang X; Gong F; Liu T; Liu Z
    Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy.
    Sandbhor P; Palkar P; Bhat S; John G; Goda JS
    Nanoscale; 2024 Mar; 16(13):6330-6364. PubMed ID: 38470224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.